Comparison of institutional review board between USA and China
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentations + Posters
- By: LI, Xiaoling (Xuanwu Hospital, Capital Medical University, Beijing, China)
- Co-author(s): Wang, Yuqin (Xuanwu Hospital, Capital Medical University, Beijing, China)
Background: Institutional Review Board (IRB) is a committee that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans. According to American and Chinese Good Clinical Practice (GCP), independent IRB is required to protect the rights and welfare of subjects in new drug clinical trials. USA.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.